Literature DB >> 15712323

Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital.

Can Liao1, Qiu-Hua Mo, Jian Li, Li-Yan Li, Yi-Ning Huang, Liang Hua, Qiu-Ming Li, Ji-Zeng Zhang, Qiong Feng, Rong Zeng, Hui-Zhu Zhong, Shi-Qi Jia, Yong Yi Cui, Xiang-Min Xu.   

Abstract

OBJECTIVES: To evaluate the first prospective screening program in China for control of alpha and beta-thalassemia in the population of pregnant couples.
METHODS: During the period between January 1993 and December 2003, a hospital-based preventive program was conducted at the biggest birth center in Guangzhou, with 1/17 of all deliveries in this city referred annually by use of conventional heterozygote screening strategy in combination with the system of regular healthcare examination in pregnancy.
RESULTS: The screened records included 49 221 pregnant women, and 4503 husbands of the pregnant women showed positive on the screening test. Of the at-risk couples, there were 198 for alpha-thal (4.4%) and 83 for beta-thal (1.8%), respectively. Genetic counseling was offered to all at-risk couples and a successful prenatal diagnosis was performed for 269 out of 281 (95.7%) for alpha- or beta-thal major, with the remaining 12 couples refusing to accept prenatal diagnosis. Out of 187 pregnancies at risk for homozygous alpha0-thal and 82 at risk for beta-thal major, 51 hydrops fetalis with Hb Bart's and 18 beta-thal major were identified. All pregnancies with affected fetuses were voluntarily terminated, leading to a marked reduction of severe alpha- and beta-thal births at this hospital since the program has been launched.
CONCLUSIONS: Our hospital-based program proved to be highly effective in reducing severe thals in pregnant populations. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15712323     DOI: 10.1002/pd.1079

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  11 in total

Review 1.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

2.  Implementation of newborn screening for hemoglobin h disease in mainland china.

Authors:  Xing-Mei Xie; Jian-Ying Zhou; Jian Li; Ru Li; Can Liao; Dong-Zhi Li
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-20       Impact factor: 0.900

3.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

Review 4.  Next generation sequencing: Coping with rare genetic diseases in China.

Authors:  David S Cram; Daixing Zhou
Journal:  Intractable Rare Dis Res       Date:  2016-08

5.  A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of α- and β-Thalassemia in China.

Authors:  Pei-Qi Chen; Qian-Ni Liang; Tao-Sheng Huang; Tian-Cai Liu; Ming Li
Journal:  J Clin Lab Anal       Date:  2016-05-26       Impact factor: 2.352

6.  Simple and Easy to Perform Preimplantation Genetic Diagnosis for β-thalassemia Major Using Combination of Conventional and Fluorescent Polymerase Chain Reaction.

Authors:  Rasoul Salehi; Sharifeh Khosravi; Mansour Salehi; Majid Kheirollahi; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2017-03-07

7.  Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples.

Authors:  Caroline E Ghiossi; James D Goldberg; Imran S Haque; Gabriel A Lazarin; Kenny K Wong
Journal:  J Genet Couns       Date:  2017-09-27       Impact factor: 2.537

8.  Measuring coverage in MNCH: a validation study linking population survey derived coverage to maternal, newborn, and child health care records in rural China.

Authors:  Li Liu; Mengying Li; Li Yang; Lirong Ju; Biqin Tan; Neff Walker; Jennifer Bryce; Harry Campbell; Robert E Black; Yan Guo
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China.

Authors:  Aihua Yin; Bing Li; Mingyong Luo; Longchang Xu; Li Wu; Liang Zhang; Yuanzhu Ma; Tingting Chen; Shuang Gao; Juqing Liang; Hao Guo; Danqing Qin; Jicheng Wang; Tenglong Yuan; Yixia Wang; Wei-wei Huang; Wen-Fei He; Yanxia Zhang; Chang Liu; Sujian Xia; Qingshan Chen; Qingguo Zhao; Xiaozhuang Zhang
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10,476 ethnically diverse couples.

Authors:  Sumin Zhao; Jiale Xiang; Chunna Fan; Xuan Shang; Xinhua Zhang; Yan Chen; Baosheng Zhu; Wangwei Cai; Shaoke Chen; Ren Cai; Xiaoling Guo; Chonglin Zhang; Yuqiu Zhou; Shuodan Huang; Yanhui Liu; Biyan Chen; Shanhuo Yan; Yajun Chen; Hongmei Ding; Fengyu Guo; Yaoshen Wang; Wenwei Zhong; Yaping Zhu; Yaling Wang; Chao Chen; Yun Li; Hui Huang; Mao Mao; Ye Yin; Jian Wang; Huanming Yang; Xiangmin Xu; Jun Sun; Zhiyu Peng
Journal:  Eur J Hum Genet       Date:  2018-10-01       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.